Cafedrine
Chemical linkage of norephedrine and theophylline
From Wikipedia, the free encyclopedia
Cafedrine (INN, BAN), sold under the brand name Akrinor among others, is a chemical linkage of norephedrine and theophylline and is a cardiac stimulant and antihypotensive agent used to increase blood pressure in people with hypotension.[1][2][3][4] It has been marketed in Europe, South Africa, and Indonesia.[4][5]
Trade namesAkrinor, Bifort, Praxinor
Other namesCaphedrine; Cafedrin; Caphedrin; Kafedrin; Norephedrino-ethyltheophylline; 7-(2-(β-Hydroxy-α-methylphen-ethylamino)ethyl)theophylline
| Clinical data | |
|---|---|
| Trade names | Akrinor, Bifort, Praxinor |
| Other names | Caphedrine; Cafedrin; Caphedrin; Kafedrin; Norephedrino-ethyltheophylline; 7-(2-(β-Hydroxy-α-methylphen-ethylamino)ethyl)theophylline |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C18H23N5O3 |
| Molar mass | 357.414 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
There has been concern about cafedrine as a potential performance-enhancing drug and doping agent in sports.[6]